APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L108. A total of 98 filers reported holding APTEVO THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,558,000 | +22.2% | 2,379,859 | +9.8% | 0.00% | 0.0% |
| Q3 2019 | $1,275,000 | -12.6% | 2,167,335 | +31.8% | 0.00% | 0.0% |
| Q2 2019 | $1,458,000 | +30.9% | 1,644,856 | +32.9% | 0.00% | 0.0% |
| Q1 2019 | $1,114,000 | -41.3% | 1,237,926 | -17.1% | 0.00% | -50.0% |
| Q4 2018 | $1,897,000 | -70.8% | 1,493,526 | +16.9% | 0.00% | -71.4% |
| Q3 2018 | $6,488,000 | -20.8% | 1,277,100 | -32.8% | 0.01% | +75.0% |
| Q2 2018 | $8,189,000 | +233.8% | 1,899,400 | +153.3% | 0.00% | +33.3% |
| Q1 2018 | $2,453,000 | +35.1% | 750,000 | +75.1% | 0.00% | +50.0% |
| Q4 2017 | $1,816,000 | +845.8% | 428,400 | +411.8% | 0.00% | – |
| Q3 2017 | $192,000 | +308.5% | 83,700 | +331.3% | 0.00% | – |
| Q4 2016 | $47,000 | -92.9% | 19,405 | -92.5% | 0.00% | -100.0% |
| Q3 2016 | $663,000 | – | 259,105 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 4,179,131 | $2,735,000 | 1.91% |
| Worth Venture Partners, LLC | 375,669 | $246,000 | 0.12% |
| Fondren Management LP | 120,184 | $79,000 | 0.08% |
| Park West Asset Management LLC | 1,000,000 | $654,000 | 0.03% |
| Point72 Asset Management, L.P. | 2,450,000 | $1,604,000 | 0.01% |
| ATLAS CAPITAL ADVISORS LLC | 49,045 | $32,099,000 | 0.01% |
| Alyeska Investment Group, L.P. | 750,000 | $491,000 | 0.01% |
| ALGERT GLOBAL LLC | 20,556 | $13,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 78,000 | $51,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 540,057 | $354,000 | 0.00% |